Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study (CYCLOFA-LUNE)
Sponsor: Charles University, Czech Republic
A PHASE2 clinical study on Lupus Nephritis and Systemic Lupus Erythematosus, this trial is completed. The trial is conducted by Charles University, Czech Republic and has accumulated 6 data snapshots since 2002. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Jan 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Charles University, Czech Republic
- Department of Rheumatology, Hospital, Ceske Budejovice, Czech Republic
- Institute of Rheumatology, Prague
- Ministry of Health, Czech Republic
- National Institute of Rheumatology, Piestany, Slovakia
- Palacky University
- St. Anna Hospital, Brno, Czech
For direct contact, visit the study record on ClinicalTrials.gov .